251 related articles for article (PubMed ID: 27318644)
1. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 3: Confirmatory testing.
Reznik Y; Amar L; Tabarin A
Ann Endocrinol (Paris); 2016 Jul; 77(3):202-7. PubMed ID: 27318644
[TBL] [Abstract][Full Text] [Related]
2. SFE/SFHTA/AFCE Consensus on Primary Aldosteronism, part 2: First diagnostic steps.
Douillard C; Houillier P; Nussberger J; Girerd X
Ann Endocrinol (Paris); 2016 Jul; 77(3):192-201. PubMed ID: 27177498
[TBL] [Abstract][Full Text] [Related]
3. SFE/SFHTA/AFCE primary aldosteronism consensus: Introduction and handbook.
Amar L; Baguet JP; Bardet S; Chaffanjon P; Chamontin B; Douillard C; Durieux P; Girerd X; Gosse P; Hernigou A; Herpin D; Houillier P; Jeunemaitre X; Joffre F; Kraimps JL; Lefebvre H; Ménégaux F; Mounier-Véhier C; Nussberger J; Pagny JY; Pechère A; Plouin PF; Reznik Y; Steichen O; Tabarin A; Zennaro MC; Zinzindohoue F; Chabre O
Ann Endocrinol (Paris); 2016 Jul; 77(3):179-86. PubMed ID: 27315757
[TBL] [Abstract][Full Text] [Related]
4. [The application of captopril challenge test in the diagnosis of primary aldosteronism].
Chen S; Zeng ZP; Song AL; Zhu L; Lu L; Tong AL; Shi C; Li HZ
Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):402-408. PubMed ID: 28592038
[No Abstract] [Full Text] [Related]
5. Confirmatory testing in primary aldosteronism.
Nanba K; Tamanaha T; Nakao K; Kawashima ST; Usui T; Tagami T; Okuno H; Shimatsu A; Suzuki T; Naruse M
J Clin Endocrinol Metab; 2012 May; 97(5):1688-94. PubMed ID: 22419718
[TBL] [Abstract][Full Text] [Related]
6. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol.
Giacchetti G; Ronconi V; Lucarelli G; Boscaro M; Mantero F
J Hypertens; 2006 Apr; 24(4):737-45. PubMed ID: 16531803
[TBL] [Abstract][Full Text] [Related]
7. MANAGEMENT OF ENDOCRINE DISEASE: The role of confirmatory tests in the diagnosis of primary aldosteronism.
Morera J; Reznik Y
Eur J Endocrinol; 2019 Feb; 180(2):R45-R58. PubMed ID: 30475220
[TBL] [Abstract][Full Text] [Related]
8. Captopril suppression: limitations for confirmation of primary aldosteronism.
Westerdahl C; Bergenfelz A; Isaksson A; Valdemarsson S
J Renin Angiotensin Aldosterone Syst; 2011 Sep; 12(3):326-32. PubMed ID: 21273222
[TBL] [Abstract][Full Text] [Related]
9. Functional tests for primary aldosteronism: value of captopril suppression.
Racine MC; Douville P; Lebel M
Curr Hypertens Rep; 2002 Jun; 4(3):245-9. PubMed ID: 12003708
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of primary aldosteronism: comparison of post-captopril active renin concentration and plasma renin activity.
Wu VC; Kuo CC; Chang HW; Tsai CT; Lin CY; Lin LY; Lin YH; Wang SM; Huang KH; Fang CC; Ho YL; Liu KL; Chang CC; Chueh SC; Lin SL; Yen RF; Wu KD;
Clin Chim Acta; 2010 May; 411(9-10):657-63. PubMed ID: 20117105
[TBL] [Abstract][Full Text] [Related]
11. The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population.
Zhu KY; Zhang Y; Zhang WJ; Li HY; Feng WH; Zhu DL; Li P
BMC Endocr Disord; 2019 Jun; 19(1):65. PubMed ID: 31234846
[TBL] [Abstract][Full Text] [Related]
12. Suppression of Aldosterone Secretion After Recumbent Saline Infusion Does Not Exclude Lateralized Primary Aldosteronism.
Cornu E; Steichen O; Nogueira-Silva L; Küpers E; Pagny JY; Grataloup C; Baron S; Zinzindohoue F; Plouin PF; Amar L
Hypertension; 2016 Oct; 68(4):989-94. PubMed ID: 27600182
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism.
Burrello J; Monticone S; Buffolo F; Lucchiari M; Tetti M; Rabbia F; Mengozzi G; Williams TA; Veglio F; Mulatero P
J Hypertens; 2016 May; 34(5):920-7. PubMed ID: 27031933
[TBL] [Abstract][Full Text] [Related]
14. Confirmatory tests in the diagnosis of primary aldosteronism.
Mulatero P; Monticone S; Bertello C; Mengozzi G; Tizzani D; Iannaccone A; Veglio F
Horm Metab Res; 2010 Jun; 42(6):406-10. PubMed ID: 20119882
[TBL] [Abstract][Full Text] [Related]
15. A new highly sensitive and specific overnight combined screening and diagnostic test for primary aldosteronism.
Tsiavos V; Markou A; Papanastasiou L; Kounadi T; Androulakis II; Voulgaris N; Zachaki A; Kassi E; Kaltsas G; Chrousos GP; Piaditis GP
Eur J Endocrinol; 2016 Jul; 175(1):21-8. PubMed ID: 27072145
[TBL] [Abstract][Full Text] [Related]
16. Baseline Plasma Aldosterone Level and Renin Activity Allowing Omission of Confirmatory Testing in Primary Aldosteronism.
Kawashima J; Araki E; Naruse M; Kurihara I; Takahashi K; Tamura K; Kobayashi H; Okamura S; Miyauchi S; Yamamoto K; Izawa S; Suzuki T; Tanabe A
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32157288
[TBL] [Abstract][Full Text] [Related]
17. Optimal use and interpretation of the aldosterone renin ratio to detect aldosterone excess in hypertension.
Doi SA; Abalkhail S; Al-Qudhaiby MM; Al-Humood K; Hafez MF; Al-Shoumer KA
J Hum Hypertens; 2006 Jul; 20(7):482-9. PubMed ID: 16617310
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of the post-captopril test in primary aldosteronism.
Castro OL; Yu X; Kem DC
Hypertension; 2002 Apr; 39(4):935-8. PubMed ID: 11967253
[TBL] [Abstract][Full Text] [Related]
19. [The aldosterone to Renin ratio in secondary hypertension].
Seiler L; Reincke M
Herz; 2003 Dec; 28(8):686-91. PubMed ID: 14689102
[TBL] [Abstract][Full Text] [Related]
20. Comparisons of plasma aldosterone and renin data between an automated chemiluminescent immunoanalyzer and conventional radioimmunoassays in the screening and diagnosis of primary aldosteronism.
Tamura N; Watanabe E; Shirakawa R; Nakatani E; Yamada K; Hatakeyama H; Torii-Hanakita M; Kyo C; Kosugi R; Ogawa T; Kotani M; Usui T; Inoue T
PLoS One; 2021; 16(7):e0253807. PubMed ID: 34242264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
